US04351N1063
US04351N1063
AscendWellness
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 83.32M EUR | 103.56M EUR | 91.27M EUR |
Enterprise Value | 677.52M EUR | 691.83M EUR | 660.99M EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -0.87x | -- | -- |
Price to Sales | 0.17x | 0.21x | 0.19x |
Price to Book | -- | -- | -- |
EV/Revenue | 1.39x | 1.42x | 1.35x |
EV/EBITDA | 14.07x | 8.13x | 8.72x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -15.77% | -19.84% | -26.2% |